US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.4421
  • -0.0629-12.46%
Close Nov 5 16:00 ET
  • 0.4465
  • +0.0044+1.00%
Pre 08:00 ET
951.02KMarket Cap-28P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclacel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 10.000K--
--2024/Q3-- / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 10.000K--
--2024/Q3-- / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--

Unlock Free Earnings Estimates

Cyclacel Pharmaceuticals Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 17:10 ET

  • 10-Q: Q1 2024 Earnings Report

    May 14 17:16 ET

  • 10-K/A: Annual report (Amendment)

    Apr 29 17:06 ET

  • Cyclacel Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 21 17:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 5, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data